Sotabase

Career

· Researcher, UCLA WiNG (Wireless Networking Group)2024–
· Graduate Student (implied from context), University of California, Los Angeles2024–
· Research Assistant, DebateStar, UCSD HSDI2019–2020
· Intern, SV Summit Inc.2019–
· Researcher (implied from context), University of California, Los Angeles

Publications (50)

Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
Cancer immunology research · 2019
171
cited
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
Journal of dentistry research · 2017
169
cited
Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
Molecular Cancer · 2017
159
cited
Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma
Cancer Immunology and Immunotherapy · 2017
147
cited
LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
Oncoimmunology · 2016
139
cited
Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma
Cellular and Molecular Life Sciences · 2017
126
cited
Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
Journal of experimental & clinical cancer research : CR · 2018
111
cited
T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
Molecular Oncology · 2017
74
cited
CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma
Oncoimmunology · 2016
69
cited
B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma
Cancer Immunology and Immunotherapy · 2016
67
cited
γ‐Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma
International Journal of Cancer · 2018
63
cited
Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma
Oncoimmunology · 2018
55
cited
Selective blockade of B7‐H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma
Journal of Cellular and Molecular Medicine · 2017
53
cited
TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
Oral Oncology · 2021
53
cited
Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma
OncoTarget · 2016
46
cited
Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma
Cellular and Molecular Life Sciences · 2018
46
cited
CD103+ T and Dendritic Cells Indicate a Favorable Prognosis in Oral Cancer
Journal of dentistry research · 2019
45
cited
CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma.
Molecular Therapy · 2023
38
cited
Improved Diagnostic Accuracy of Ameloblastoma and Odontogenic Keratocyst on Cone-Beam CT by Artificial Intelligence
Frontiers in Oncology · 2022
36
cited
Specific blockade CD73 alters the “exhausted” phenotype of T cells in head and neck squamous cell carcinoma
International Journal of Cancer · 2018
34
cited
Sotabase
Mao, Liang | Researcher Profile | Sotabase | Sotabase